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Pityriasis rosea: a natural history of pediatric cases in the
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Background/aim: This study aimed to evaluate the demographic, clinical, and epidemiological features of pityriasis rosea (PR) in a
cohort of 46 children in Yozgat, a city in the Central Anatolia Region of Turkey.
Materials and methods: Forty-six children with PR were monitored at regular intervals (1, 2, 4, and 12 weeks) for 3 months from the
time of diagnosis. A complete evaluation of the patient was performed at each visit.
Results: The average age of patients at time of diagnosis was 12 ± 3.9 years. Cases were most common in the winter (rainy, snowy
months; n = 14, 31%). Fifteen patients had a medical history significant for the presence of upper respiratory tract infection, while skin
PR manifestations were preceded by drug intake in a second group of 15 patients. The presence of a herald patch was observed in 78.3%
of patients, most frequently on the trunk (n = 23). Pruritus occurred in 75% of patients. Median PR duration was 3 weeks (range: 1–20
weeks).
Conclusion: The course of PR is similar in Turkish children and adults. The high prevalence of pruritus in children with PR in Turkey
was also significant. Further evaluation of this finding comparing adults and children is now required.
Key words: Children, clinical features, pityriasis rosea

1. Introduction
Pityriasis rosea (PR) is an entirely self-mitigating acute
papulosquamous disease with no known cause. Both
bacterial and viral agents have been proposed, although
convincing experimental evidence is lacking. PR is
typically characterized by the emergence of a herald patch
and subsequently the diffusion of a papulosquamous rash
running parallel along skin cleavage lines. PR typically
resolves within 6–8 weeks. Few reports of pediatric PR are
currently available (1–4).
The present study summarizes the demographic,
clinical, and epidemiological features of PR in a cohort of
46 children in Yozgat, a city in the Central Anatolia Region
of Turkey.

2. Materials and methods
2.1. Sample size
Forty-six patients between 1 and 18 years of age presenting
to the Bozok University Faculty of Medicine’s Infectious
Disease, Dermatology, or General Pediatrics Clinics and
diagnosed with PR were enrolled between January 2012 and
January 2013. In agreement with the literature, diagnosis
of PR was in most cases based on history and physical
exam. In atypical cases a skin biopsy was performed by a
dermatologist to differentiate PR from other exanthemas
(3,5). Patients with inconclusive diagnoses were considered
ineligible for participation.
Standardized forms were used to collect patient data
at the time of diagnosis, including sex and age, presence
and location of herald patch, time of lesion onset, duration
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of symptoms, distribution and type of lesions, presence
of pruritus, previous upper respiratory tract infection
(URTI), history of exposure to PR, and medication use.
Forty-six children with PR were monitored at regular
intervals (1, 2, 4, and 12 weeks) for 3 months from the
time of diagnosis. A complete evaluation of the patient was
performed at each visit. The study protocol was reviewed
and approved by the Bozok University Medical Faculty
Ethics Committee. Parents provided informed consent for
all participating children.
2.2. Statistical analysis
Statistical analyses were performed with SPSS 15. The
chi-square test or Fisher’s exact test, as appropriate, was
used for comparisons in different groups. P < 0.05 was
considered statistically significant.
3. Results
The 46 patients with PR in the study group consisted of 30
females and 16 males. Mean patient age was 12 ± 3.9 years.
PR was more common in winter (rainy, snowy months;
n = 14.31%), followed by fall (n = 12.27%), spring (n =
11. 22%), and summer (n = 9.20%). Medical history
included URTI in 15 patients, while drug intake prior to
the skin manifestations was present in another 15. The
most common drugs used before onset of the rash were
antipyretics and nonsteroidal antiinflammatory drugs.
A herald patch was observed in 78.3% of patients, most
often on the trunk (n = 23). The median time between
appearance of a herald patch and eruption of widespread
lesions was 4 days (range: 0–30). Approximately 93% of
patients had characteristic papulosquamous lesions, 4.3%
had purely papular lesions, and 2.2% had papulovesicular
lesions. No oral lesions or residual pigmentary changes
were observed. Pruritus was reported in 74% of patients.
No significant differences were determined in terms
of sex, distribution, history of URTI, or drug use (P >
0.05). However, duration of inverse distribution (n =
2) was greater (median: 17 weeks) compared to other
distributions (P < 0.05).
The disease resolved within 2 weeks after the onset
of symptoms in approximately half of the patients.
Improvement was observed in 2–4 weeks in 28.3%
of cases. Active disease lasting more than 4 weeks
occurred in only 20% of cases. One patient withdrew
from monitoring. Disease concurrence is defined as the
presence of PR among individuals in close contact with the
patient. Household contact with other individuals with PR
occurred in 2 cases (4.3%). One parent reported that the
patient had experienced a previous episode of PR (disease
recurrence rate: 2.2%).
Oral antihistamines were the most common medication
used among PR patients (n = 37). The Table summarizes
the study results.

Table. Clinical and epidemiological features of the patients with
pityriasis rosea.
Characteristics
Sex
Female
Male
Season of onset
Winter
Fall
Spring
Summer
Pruritus
Signs
Herald patch
Type of lesion
Papulosquamous
Papular
Papulovesicular
Distribution of lesions
Central
Diffuse
Peripheral
Inverse
Duration
Resolution <2 weeks
Resolution 2–4 weeks
Resolution >4 weeks
Lost to follow-up
Recurrence
Treatment
Oral antihistamines*
Topical corticosteroids*
Oral antibiotics*
Systemic steroids*

n (%)

30 (65.2)
16 (34.8)
14 (31)
12 (27)
11 (22)
9 (20)
34 (74)
36 (78.3)
43 (93.5)
2 (4.3)
1 (2.2)
32 (69.6)
10 (21.7)
2 (4.3)
2 (4.3)
23 (50)
13 (28.3)
9 (20)
1 (2.2)
1 (2.2)
37 (80.4)
20 (43.5)
5 (10.9)
2 (4.3)

*Used alone or in combination with other treatments.

4. Discussion
PR is a common acute exanthema (4). Limited data are
available concerning its prevalence in children. Gül et
al. determined a prevalence of PR of 1.27% in a study
involving the pediatric age group (6). The causes of PR are
unclear, although the use of certain medications, stress,
pregnancy, and infection have all been implicated (7–13).
Of our study group, 32.6% had a prior history of URTI.
Peak incidence occurred in winter and fall, a finding
that is supported by the available literature (4,14).
We postulate that a decrease in ambient temperature
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suppresses cellular immunity, promoting disease among
vulnerable individuals.
Pruritus has been reported in 25% of adult patients
and 69%–90% of pediatric PR patients, and pruritus
was identified in 74% of our cases (1,2,4). The incidence
of pruritus in our study was higher than the typical rate
reported for adult patients, but comparable to previous
reports in pediatric populations.
In addition, 78.3% of our patients exhibited a herald
patch, which is compatible with the previously reported
range of 12%–94% (15). Our rates for household
concurrence, 4.3% (in 2 patients), and recurrence, 2.2%,
were both within previously cited ranges of 1%–4.6% and
1.4%–2.8%, respectively (16). Secondary lesions in PR are
very similar to the herald patch, although they are always
smaller. Gigantean (larger and fewer lesions), pustular,
purpuric, and vesicular PR cases are rare. The trunk,
abdomen, and neck are the most common sites, while
the extremities and face are rarely involved (4,17). In our
pediatric patients with PR, the classical papulosquamous
type located on the trunk (93.5%) was the most common
manifestation.
Active lesions resolved within 2 weeks in half of our
cases and within 4 weeks in 78.3%, a rate similar to that
seen in African-American children (2).

Seventy-four percent of our patients had pruritus.
Scratching of lesions can lead to secondary infection and
scarring. It seems reasonable to offer patients relief from
their pruritus and to prevent nonpigmentary sequelae
through the application of systemic antihistamines, mild
topical steroids, or both (2,17). Oral antibiotics were
prescribed to 5 patients with possible bacterial infection,
and systemic steroid therapy was provided for 2 patients
not responding to systemic antihistamines and topical
steroids.
In contrast to our study conducted in a Turkish
pediatric population, PR involving the scalp and face in
African-American children is often extensive and papular
and leaves residual pigmentary changes in the majority of
patients (2). This suggests that genetic factors are involved
in the etiology and course of PR.
In conclusion, the course of PR is similar in Turkish
children and adults. We observed a higher incidence of
disease during rainy and snowy months. URTI preceded
the emergence of rash in 32.6% of our patients. Another
significant finding was the high prevalence of pruritus,
which resolved rapidly in our PR cases. Further studies
with larger patient numbers are now needed to compare
PR symptoms in different age cohorts and ethnic groups.
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